立中集團(300428.SZ)子公司獲21.7億元鋁合金車輪項目定點
格隆匯11月3日丨立中集團(300428.SZ)公吿,公司子公司新泰車輪、保定車輪分別於近日收到客户1、客户2、客户3鋁合金車輪項目的定點通知,客户1項目預計2026年7月開始量產,項目生命週期3-6年,預計項目週期內銷售金額約13.8億元;客户2項目預計2025年2月開始量產,項目生命週期2年,預計項目週期內銷售金額約5.3億元;客户3鍛造鋁合金車輪項目預計2025年3月開始量產,項目生命週期4年,預計項目週期內銷售金額約2.6億元。客户1、客户2、客户3預計項目週期內銷售額合計約21.7億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.